HKMPYHikma Pharmaceuticals plc.

About Hikma Pharmaceuticals plc. (HKMPY)

Hikma Pharmaceuticals plc. (HKMPY) is a Drug Manufacturers - Specialty & Generic company headquartered in London, ENG, United Kingdom whose shares trade over-the-counter on the Pink tier.

Hikma helps put better health within reach every day for millions of people in more than 50 countries around the world. For more than 40 years, we've been creating high-quality medicines and making them accessible to the people who need them. Headquartered in the UK, we are a global company with a local presence across the United States (US), the Middle East and North Africa (MENA) and Europe, and we use our unique insight and expertise to transform cutting-edge science into innovative solutions that transform people's lives. We're committed to our customers, and the people they care for, and by thinking creatively and acting practically, we provide them with a broad range of branded and non-branded generic medicines. Together, our 8,400 colleagues are helping to shape a healthier world that enriches all our communities. We are a leading licensing partner, and through our venture capital arm, are helping bring innovative health technologies to people around the world.

HKMPY key facts

Ticker symbol

HKMPY

Market tier

Pink

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Headquarters

London, ENG, United Kingdom

Country of incorporation

GB

Year of incorporation

1978

Estimated market cap

$5.44B (as of Apr 9, 2025)

Shares outstanding

231,000,000

Reporting standard

International Reporting: LSE - London Stock Exchange

Audit status

Audited

Fiscal year end

12/31

Hikma Pharmaceuticals plc. leadership

• Said Darwazah — CEO
• Bassam Kanaan — EVP, CFO

Explore more: Drug Manufacturers - Specialty & Generic stocks · Healthcare sector · Pink stocks · OTC stocks starting with H